Teva Confirms Generic Victoza Patent Challenge in the United States
Teva Pharmaceutical Industries Ltd., announced that it has filed an abbreviated new drug application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market…
Read More...
Read More...
